BioCrowd

BioCrowd is building the financial infrastructure to transform how clinical research is funded and commercialized.

BioCrowd as the NASDAQ for FDA milestones.

[BioCrowd @BioCrowdIO]

The leaders of @JohnsHopkins, @MIT & @UnivOfKansas just published a collective alarm:
"the federal research engine has sputtered."

Numbers from May 2026:

NIH new grants: -48%
NSF new grants: -65%
Johns Hopkins portfolio: -$500M
MIT research activity: -20%
Next-gen scientist awards: -75%

Unspent funds return to U.S. Treasury
on Sep 30, 2026.

The clock is running.
Institutions need alternative capital now.

Source: @AAUniversities, May 28, 2026

#ResearchFunding #NIH #BioCrowd #DeSci

[BioCrowd @BioCrowdIO]

Alternative capital infrastructure.
Milestone-based funding.
Donor-Advised Funds + impact investors + family offices reaching research institutions compliantly.

BioCrowd = the infrastructure layer for this moment.
Not instead of NIH. Alongside it.

#ResearchFunding #BioCrowd

[BioCrowd @BioCrowdIO]

Only 15% of external research funding was obligated by March.

383 clinical trials delayed.
Billions sitting idle.

The U.S. research funding system is experiencing structural failure.

This is not temporary.

This is an operational crisis.

#ResearchFunding #NIH #BioCrowd

[BioCrowd @BioCrowdIO]

Translational research programs are being hit hardest:

-Oncology
-Neuroscience
-Rare disease
-IND-enabling work

Not because the science failed.
Because the funding infrastructure failed.

Early-career researchers are leaving the system.

The policy fix takes years.
Institutions need solutions now.

#Biotech #DeSci #RWA

[BioCrowd @BioCrowdIO]

Research funding doesn't need better fundraising tools.

It needs better infrastructure.

Last week's the Business of Blockchain & Tokenization Conference at @MiamiHerbert
watching the academic layer build exactly that.

ContractLLM.
Governance frameworks.
Verifiable capital rails.

BioCrowd is building on top.

#BBT #Blockchain #RWAs #DeSci #BioCrowd

[BioCrowd @BioCrowdIO]

The most telling sign of a maturing market

The room stops talking about price
and starts talking about what gets built on top of the rails.

#CryptoPoloCup #BioCrowd #PalmBeach

[BioCrowd @BioCrowdIO]

Great to see @nikichain & @LunaPRofficial bringing the right people into the same room.

DeSci founders and healthcare VCs...
this is the convergence moment!

What are your thoughts on the future of biotech infrastructure?

#BioCrowd

[BioCrowd @BioCrowdIO]

Palm Beach -> Miami -> Dubai

The geography of crypto capital is changing fast.

We were at the #CryptoPoloCup last weekend & here's what the room was actually talking about 🧵

[BioCrowd @BioCrowdIO]

Tokenised assets.
Programmable finance.
Stablecoin rails.
Institutional adoption.

The rails are ready.

The question is?
What gets funded on top of them?

Our answer: medical research.

[BioCrowd @BioCrowdIO]

@cryptopolocup Great conversations with @nikichain and the @LunaPRofficial team

Building serious bridges across Web3, AI & institutional finance.

Looking forward to connecting with DeSci and healthcare VCs to chat on biotech RWA infrastructure.

#CryptoPoloCup #BioCrowd #LunaPR

[BioCrowd @BioCrowdIO]

BTS from @cryptopolocup 2026, Palm Beach.

Institutional capital.
Digital assets.
RWAs.

All in one room.

The infrastructure conversation is happening.
and we are building the biotech layer of it.

#CryptoPoloCup #DeSci #BioCrowd

[BioCrowd @BioCrowdIO]

The rails crypto built
-stablecoins
-programmable capital
-onchain settlement
are exactly what medical research funding has been missing.

$300B in idle DAFs.
FDA-verified milestones.
IRB-approved research.

Tokenise the milestones.
Fund the science.

That's us!

#RWAs #DeSci #Biotech

[BioCrowd @BioCrowdIO]

Day 2. Capital Markets Summit at Consensus Miami.

The session: how onchain infrastructure is redefining asset issuance + settlement.

Our read: FDA milestones are the most underleveraged RWA in existence.

$300B idle DAFs
NIH -40%
The timing doesn't get more obvious.

BioCrowd is the infrastructure.

#Consensus2026 #RWA #DeSci #BioCrowd

[BioCrowd @BioCrowdIO]

DeSci VCs + family offices at #Consensus2026

Health RWAs are the next real-world asset class.

IRB-verified milestones.

FDA research assets.

DAF capital onchain.

We want to act as biotech's RWA infrastructure layer.

#Consensus2026 #HealthRWA

[BioCrowd @BioCrowdIO]

Consensus 2026, Miami
1,000+ in line before doors open. 🧬

@BioCrowdIO is ready to see DeSci meet biotech capital infrastructure.

20K+ attendees.
The energy is real.

Floor reports all week.
#Consensus2026 #DeSci

[BioCrowd @BioCrowdIO]

Stablecoins session just confirmed it

Onchain capital rails = solved.

Next unlock:
Tokenized hospital Phase 1 milestones as RWAs.

$300B in idle DAFs → translational research funding in 90 days.

NIH -40%. VC at 5-yr lows.
The infrastructure gap is BioCrowd's market.

#DeSci #RWA #BioCrowd

[BioCrowd @BioCrowdIO]

Last week's Cooley Healthtech Conference in Palo Alto was full of people shaping healthtech's next chapter.

One thing was clear:
The ecosystem doesn't need more noise.
It needs better infrastructure to connect the right people 🧬

#HealthTech #BioCrowd #CA #eMergeAmericas

[BioCrowd @BioCrowdIO]

AI in healthcare.
Neural data law.
Investor panels.
Regulatory updates from Washington.

The Cooley Healthtech Conference covered it last week in Palo Alto.

The through-line?
Infrastructure - for capital, for compliance, for community

#HealthTech #BioCrowd #DigitalHealth #AmericanBTC #eMergeAmericas

[BioCrowd @BioCrowdIO]

@EricTrump Milestone-triggered capital.
IRB-compliant.
DAF-eligible.

Blockchain-verified.

If $500M can move in a year for Bitcoin
imagine what the right infrastructure unlocks for cancer research.

We're building it.

#eMergeAmericas #BioCrowd #HealthTech #ResearchFunding #Biocoin

[BioCrowd @BioCrowdIO]

When @EricTrump just spoke about Biocoin, American Bitcoin raised $500M+ in a year as a public company.

One thing is clear:
when capital infrastructure is right,
money moves fast.

Medical research deserves the same.🧵

[BioCrowd @BioCrowdIO]

@EricTrump The lesson from crypto capital isn't about the asset.
It's about the rails.

When the infrastructure is compliant, transparent, and milestone-driven....
investors show up!

Clinical research has the science.

It's been missing the rails.

That's the gap @BioCrowdIO closes.